featured
Outcomes With GLP-1 Receptor Agonists in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiovascular, Mortality, and Kidney Outcomes With GLP-1 Receptor Agonists in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Trials
Lancet Diabetes Endocrinol 2021 Aug 20;[EPub Ahead of Print], N Sattar, MMY Lee, SL Kristensen, KRH Branch, S Del Prato, NS Khurmi, CSP Lam, RD Lopes, JJV McMurray, RE Pratley, J Rosenstock, HC GersteinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.